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Le Goff et al., page 7
Two types of acromelic dysplasia, geleophysic dysplasia
(GD) and acromicric dysplasia (AD), are clinically defined
disorders each of which is characterized by extreme short
stature with bone and joint abnormalities and distinct
facial features. In this issue, Le Goff and colleagues use
exome sequencing and subsequent Sanger sequencing to
identify mutations in FBN1 in individuals with GD and
in those with AD. The involvement of FBN1disruption in
these growth disorders is particularly interesting because
mutations in the gene are known to cause Marfan
syndrome for which tall stature is a defining phenotype.
How can disruption of the same gene lead to such different
clinical presentations? The authors analyze their muta-
tions in an effort to start to address that question. Of
particular note is that each of the 16 mutations identified
in individuals with GD or AD is located in the region
that encodes the TGF-b binding protein like 5 (TB5)
domain. In patient cells, these mutations disrupt microfi-
bril formation and organization and enhance TGF-
b signaling. TGF-b activation is also seen in Marfan
syndrome, so additional regulatory factors must be
involved in the differential mutation effects. One player
may be ADAMTSL2. The gene encoding ADAMTSL2 has
been shown previously to be mutated in individuals with
GD, and here, Le Goff et al. demonstrate that FBN1 and
ADAMTSL2 interact directly with each other. Additional
analyses will contribute to our growing interest!Age and Acetylation
Rope et al., page 28
Posttranslational modifications (PTMs) are changes made
to proteins after translation. PTMs come in many forms
and provide tissue and temporal diversity to proteins.
Presumably, this diversity results in specialized function
not provided by the amino acid sequence alone. Acetyla-
tion is one such PTM. Although 80%–90% of human
proteins have been found to be modified via N-terminal
acetylation, remarkably little is known about the enzyme
complexes completing this task or the impact of this
type of modification. N-acetyltransferases are enzymes
that transfer acetyl groups (CH3CO) from acetyl-CoA to
arylamines (including amino acids). The NatA complex is1Science Editor, AJHG; 2Deputy Editor, AJHG
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It is composed of a catalytic subunit, ARD1 (encoded by
NAA10), and an auxiliary subunit, either NATH (encoded
by NAA15) or NMDA receptor regulated 1 like (encoded
by NAA16). NatA is thought to play a role in cancer
progression and organisms (including flies and worms)
lacking the catalytic subunit do not survive. In this issue,
Rope and colleagues identify the same NAA10 mutation
in two independent and unrelated families presenting
with premature aging and other symptoms of what
appears to be a new lethal syndrome. Although the exact
modifications affected by this mutation are yet to be deter-
mined, this study highlights the importance of PTM,
specifically N-terminal acetylation, in health and develop-
ment. The study also demonstrates the utility of a new
tool, VAAST, that can be used to prioritize variants found
through exome sequencing.To Combine but Not Collapse
Wu et al., page 82
We’re getting pretty good at doing a whole lot of
sequencing, but how well can we determine whether
rare variants identified via sequencing are associated with
a phenotype? Those developing the methodology to
perform such analyses have been working hard to keep
pace with the explosion of technological advancements.
Many of the first series of programs to deal with rare
variants combine together the rare variants found in
a region in order to establish that variation within that
region is associated; a single variant found in a very small
number of individuals isn’t enough to produce a significant
signal, but assessing several such signals together could
establish an association with a functional unit disrupted
by a diverse set of variants. These approaches are prom-
ising, but one limitation of some of the early methods is
that if some variants in a region increase risk and other
decrease risk, these signals will cancel each other out.
Now, the next round of methods is focusing on combining
signals from variants within a region while accommo-
dating the fact that the variants may have effects in
opposite directions. In this issue, Wu and colleagues
present their sequence kernel association test (SKAT) that
accomplishes this goal and that can be used to test for
association between rare and common variants with
both qualitative and quantitative phenotypes.Genetics. All rights reserved.
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Where Do the Siddis Come From?
Narang et al., page 111; Shah et al., page 154
Throughout history, human exploration, migration,
conquest, and collaboration have resulted in the
mingling of genetically distinct populations. Studying
the way in which genetic regions are arranged in the
resultant admixed populations can not only provide
insight into the demographic history of the people, but
can also contribute to an understanding of how variants
within those regions may be associated with traits and
diseases. When two ancestral populations are mixed
together, large sections of DNA will remain intact in the
subsequent generations. As time passes, the length of
these regions will be shortened by recombination, but if
the admixture event is recent enough, the extended
linkage disequilibrium (LD) of these pieces of DNA can
be used as a tool in mapping genetic associations. In
this issue, Narang and colleagues and Shah and colleagues
report their independent analyses of the genetic structure
of the Siddis people who live in Western India. Previous
work had suggested that the Siddis derived their ancestry
from India, Africa, and Portugal, but additional work was
needed for clarifying the exact populations that contrib-
uted to the Siddis and the timing of the admixture. Their
findings support that the ancestral African contribution
to the Siddis came from sub-Saharan Bantu-speaking
African slaves brought to India by the Portuguese. In
addition, the groups demonstrate that the admixture
event in the Siddis was recent enough and the extended
regions of LD are long enough that the population is
likely to serve as an important resource for admixture
mapping.2 The American Journal of Human Genetics 89, 1–2, July 15, 2011Expanding to 36 SCAs
Kobayashi et al., page 121
Typically, whenwe think of genetic alterations, single-nucle-
otide polymorphisms (SNPs), common variants that do not
significantly (if at all) alter protein structure or function,
and point mutations, changes that result in altered protein
and disease, spring to mind. However, trinucleotide repeat
number is another common variation, one that is only toler-
ated to a certain point. Since the early 1990s, when fragile X
syndrome was found to be caused by an expansion of the
CGG trinucleotide repeat, more attention to these genetic
expansions has been paid and more diseases and syndromes
have been attributed to expanding nucleotide repeats. CAG,
encoding for glutamine, is the most common trinucleotide
repeat.Thus,most trinucleotiderepeatdiseasescanbeconsid-
ered polyglutamine diseases. These include Huntington
disease and several different spinocerebellar ataxias (SCAs).
Trinucleotide expansion disorders not encoding glutamine
are grouped together as non-polyglutamine diseases. These
include additional neurological conditions such as Friedreich
ataxia, myotonic dystrophy, and additional forms of SCA.
In this issue, Kobayashi and colleagues identify yet another
ataxia, SCA36, caused by nucleotide repeat expansion.
Instead of the typical trinucleotide repeat, SCA36 is caused
by expansionof ahexonucleotide repeat.Another distinctive
feature is that the repeat is located in a noncoding region of
NOP56. The authors show that the disease is probably caused
by a gain of function of RNA foci, as is thought to be the case
for other SCAs. While anticipation, whereby symptoms of
disease appear earlier in later generations of the affected,
does not appear to apply to SCA36, we do anticipate an ex-
panding interest in this type of genetic alteration.
